Biomedical Data Analysis Seven Bridges Genomics specializes in accelerating precision medicine through the analysis of biomedical data, offering opportunities for collaborations with healthcare providers and pharmaceutical companies seeking advanced bioinformatics solutions.

BCO Standard Development The collaboration with the BioCompute Object community to develop the BCO standard for NGS workflows presents sales opportunities for regulatory compliance tools and applications, particularly in the genomics and biotechnology sectors.

Partnership with NIH The partnership with the National Institutes of Health on the INCLUDE Project opens doors for sales to institutions involved in investigating co-occurring medical conditions, showcasing capabilities for large-scale research collaborations.

Precision Medicine Merger The acquisition by Summa Equity AB and merger into Velsera positions Seven Bridges Genomics within a newly formed precision medicine company, offering sales prospects for integrated healthcare solutions and genetic research services.

Unified Patient Network Launch The formation of the Unified Patient Network subsidiary focuses on facilitating clinical research and collaboration with health systems and biopharma companies, creating sales opportunities for data management and patient-centric precision medicine solutions.